RhumbLine Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-114,265
| Closed | -$231K | – | 3317 |
|
|
2022
Q1 | $231K | Buy |
114,265
+1,388
| +1% | +$2.81K | ﹤0.01% | 2725 |
|
|
2021
Q4 | $306K | Buy |
112,877
+4,894
| +5% | +$13.3K | ﹤0.01% | 2697 |
|
|
2021
Q3 | $482K | Buy |
107,983
+2,411
| +2% | +$10.8K | ﹤0.01% | 2563 |
|
|
2021
Q2 | $612K | Buy |
105,572
+4,044
| +4% | +$23.4K | ﹤0.01% | 2471 |
|
|
2021
Q1 | $713K | Sell |
101,528
-5,908
| -5% | -$41.5K | ﹤0.01% | 2335 |
|
|
2020
Q4 | $516K | Buy |
107,436
+8,955
| +9% | +$43K | ﹤0.01% | 2435 |
|
|
2020
Q3 | $574K | Sell |
98,481
-17,617
| -15% | -$103K | ﹤0.01% | 2223 |
|
|
2020
Q2 | $784K | Buy |
116,098
+49,504
| +74% | +$334K | ﹤0.01% | 2144 |
|
|
2020
Q1 | $424K | Sell |
66,594
-194
| -0.3% | -$1.24K | ﹤0.01% | 2242 |
|
|
2019
Q4 | $696K | Buy |
66,788
+305
| +0.5% | +$3.18K | ﹤0.01% | 2230 |
|
|
2019
Q3 | $261K | Sell |
66,483
-80
| -0.1% | -$314 | ﹤0.01% | 2638 |
|
|
2019
Q2 | $990K | Buy |
66,563
+3,286
| +5% | +$48.9K | ﹤0.01% | 2073 |
|
|
2019
Q1 | $1.57M | Sell |
63,277
-685
| -1% | -$17K | ﹤0.01% | 1839 |
|
|
2018
Q4 | $1.15M | Buy |
63,962
+19,840
| +45% | +$356K | ﹤0.01% | 1936 |
|
|
2018
Q3 | $1.3M | Sell |
44,122
-3,464
| -7% | -$102K | ﹤0.01% | 1880 |
|
|
2018
Q2 | $2.16M | Buy |
47,586
+4,110
| +9% | +$187K | ﹤0.01% | 1639 |
|
|
2018
Q1 | $2.3M | Sell |
43,476
-1,129
| -3% | -$59.6K | ﹤0.01% | 1520 |
|
|
2017
Q4 | $3.03M | Sell |
44,605
-9,104
| -17% | -$619K | 0.01% | 1376 |
|
|
2017
Q3 | $4.43M | Buy |
53,709
+6,208
| +13% | +$512K | 0.01% | 1106 |
|
|
2017
Q2 | $4.45M | Buy |
47,501
+2,370
| +5% | +$222K | 0.01% | 1076 |
|
|
2017
Q1 | $2.87M | Buy |
45,131
+7,196
| +19% | +$458K | 0.01% | 1345 |
|
|
2016
Q4 | $1.69M | Buy |
37,935
+3,612
| +11% | +$160K | ﹤0.01% | 1551 |
|
|
2016
Q3 | $1.24M | Buy |
34,323
+276
| +0.8% | +$9.95K | ﹤0.01% | 1701 |
|
|
2016
Q2 | $467K | Buy |
34,047
+3,020
| +10% | +$41.4K | ﹤0.01% | 2235 |
|
|
2016
Q1 | $596K | Buy |
31,027
+790
| +3% | +$15.2K | ﹤0.01% | 2102 |
|
|
2015
Q4 | $1.06M | Buy |
30,237
+1,880
| +7% | +$65.8K | ﹤0.01% | 1763 |
|
|
2015
Q3 | $2.61M | Buy |
28,357
+1,851
| +7% | +$170K | 0.01% | 1173 |
|
|
2015
Q2 | $2.33M | Sell |
26,506
-900
| -3% | -$79.1K | 0.01% | 1296 |
|
|
2015
Q1 | $2.03M | Buy |
27,406
+4,620
| +20% | +$343K | 0.01% | 1396 |
|
|
2014
Q4 | $1.28M | Buy |
22,786
+525
| +2% | +$29.4K | ﹤0.01% | 1640 |
|
|
2014
Q3 | $1.01M | Sell |
22,261
-1,630
| -7% | -$74K | ﹤0.01% | 1749 |
|
|
2014
Q2 | $989K | Buy |
23,891
+5,064
| +27% | +$210K | ﹤0.01% | 1829 |
|
|
2014
Q1 | $1.3M | Buy |
18,827
+1,530
| +9% | +$106K | ﹤0.01% | 1633 |
|
|
2013
Q4 | $1.04M | Buy |
17,297
+2,620
| +18% | +$158K | ﹤0.01% | 1781 |
|
|
2013
Q3 | $892K | Buy |
14,677
+1,353
| +10% | +$82.2K | ﹤0.01% | 1848 |
|
|
2013
Q2 | $892K | Buy |
+13,324
| New | +$892K | ﹤0.01% | 1840 |
|